Gregory J. Flesher
2020 - Reneo Pharmaceuticals
In 2020, Gregory J. Flesher earned a total compensation of $132.9K as Chief Executive Officer and President at Reneo Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $39,600 |
|---|---|
| Salary | $79,167 |
| Other | $14,180 |
| Total | $132,947 |
Flesher received $79.2K in salary, accounting for 60% of the total pay in 2020.
Flesher also received $39.6K in non-equity incentive plan and $14.2K in other compensation.
Rankings
In 2020, Gregory J. Flesher's compensation ranked 12,821st out of 13,090 executives tracked by ExecPay. In other words, Flesher earned more than 2.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,821 out of 13,090 | 2nd |
Division Manufacturing | 5,506 out of 5,621 | 2nd |
Major group Chemicals And Allied Products | 2,215 out of 2,254 | 2nd |
Industry group Drugs | 1,922 out of 1,954 | 2nd |
Industry Pharmaceutical Preparations | 1,433 out of 1,459 | 2nd |
Source: SEC filing on April 22, 2022.
News
Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
April 26, 2023
Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
April 22, 2022
Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
March 31, 2020
Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
May 15, 2019